A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 116.47
GOOG 537.50
MSFT 47.98
BAC 17.12
FB 73.75

Recently Added

SPG 178.45
R 91.82
SKX 58.86
CTRE 15.57
BBRY 10.24

Gaining Speed

SPG 178.45
TMO 126.54
ETH 29.22
BABA 110.73
BA 132.78

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!